Our website uses cookies to provide your browsing experience and relevant information. Before continuing to use our website, you agree & accept our Cookie Policy & Privacy.

Two popular diabetes drugs outperformed others in large clinical trial

finchannel.com

Two popular diabetes drugs outperformed others in large clinical trial

NIH-funded researchers complete first study comparing commonly used type 2 diabetes medications. In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range. Blood glucose management is a key component of keeping people with type 2 diabetes healthy. All four medications evaluated were added to treatment with metformin, which is the first-line drug to treat type 2 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health.
  • Last
More news

News by day

Today,
1 of September 2025

Related news

More news